ICER Colloquium Series, Pricing in a Pandemic | Session Two: Cost-Effectiveness and Value-Based Pricing 07/27/2020
ICER Indefinitely Postpones Public Meetings for Sickle Cell Disease and Cystic Fibrosis; Expands Other Assessment Timelines Up to Three Months 03/20/2020
ICER’s New Patient Engagement Program: Amplifying the Patient Voice Before, During, and After a Value Assessment 03/10/2020
